Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan-Reference-Cited by-同舟云学术

Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan

Published:2011-06-28 Issue:9 Volume:31 Page:1366-1372
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Shirabe Ken,Toshima Takeo,Taketomi Akinobu,Taguchi Kennichi,Yoshizumi Tomoharu,Uchiyama Hideaki,Harimoto Norifumi,Kajiyama Kiyoshi,Egashira Akinori,Maehara Yoshihiko

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2011.02572.x/fullpdf

Reference34 articles.

1. Epidemiology, risk factors, and natural history of hepatocellular carcinoma;Montalto;Ann NY Acad Sci,2002

2. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan;Shiratori;Hepatology,1995

3. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan;Nishioka;Cancer,1991

4. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey;Ozdemir;J Gastrointest Cancer,2010

5. Mycotoxins in rice;Tanaka;Int J Food Microbiol,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions;Antioxidants;2024-04-11

2. Imaging the cellular response to an antigen tagged interstrand crosslinking agent;DNA Repair;2023-08

3. Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area;Nutrients;2022-04-15

4. Immunohistochemical Detection of Aflatoxin in Lesions of Aflatoxin-producing Aspergillus flavus Infection;Medical Mycology Journal;2021

5. Metabolic Syndrome Instead of Aflatoxin-Related TP53 R249S Mutation as a Hepatocellular Carcinoma Risk Factor;Revista de investigaci�n Cl�nica;2020-11-09